Published in Lancet on December 11, 1982
Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest (2000) 1.84
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol (2009) 1.78
Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.44
HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol (2010) 1.32
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) (2013) 1.23
An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol (2009) 1.17
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens (2010) 1.05
Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol (2014) 1.02
Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J (Clin Res Ed) (1987) 1.02
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metab (2016) 1.00
Kidney aging--inevitable or preventable? Nat Rev Nephrol (2011) 0.99
Dyslipidemia in children with chronic kidney disease. Kidney Int (2010) 0.99
Associations of dietary fat with albuminuria and kidney dysfunction. Am J Clin Nutr (2010) 0.99
Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice. PLoS One (2014) 0.92
Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis (1997) 0.89
Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation. Inflamm Res (2009) 0.88
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech (2012) 0.86
An update on 'progression promoters' in renal diseases. J Natl Med Assoc (2003) 0.84
Nuclear receptors in renal disease. Biochim Biophys Acta (2011) 0.84
Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults. J Korean Med Sci (2012) 0.84
Obesity-Related Chronic Kidney Disease-The Role of Lipid Metabolism. Metabolites (2015) 0.83
Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia. Kidney Int (2012) 0.83
Interventions in chronic renal failure. BMJ (1990) 0.83
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients. Open Cardiovasc Med J (2007) 0.82
Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia. Am J Pathol (1989) 0.82
Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif (2013) 0.82
Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury. Front Endocrinol (Lausanne) (2014) 0.81
Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis. Pediatr Nephrol (2007) 0.81
Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials. Rev Diabet Stud (2013) 0.81
Albuminuria and its correlates in an Iranian type 2 diabetic population. Lipids Health Dis (2008) 0.81
Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean National Health and Nutrition Examination Survey. J Korean Med Sci (2012) 0.81
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus. Drug Des Devel Ther (2011) 0.80
A new mouse model of metabolic syndrome and associated complications. J Endocrinol (2009) 0.80
High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney. J Nutr Biochem (2009) 0.80
Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol (2012) 0.80
Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female rats. Food Nutr Res (2016) 0.80
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol (2014) 0.79
Vancomycin-Associated Nephrotoxicity: The Obesity Factor. Surg Infect (Larchmt) (2015) 0.79
A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome. Nephron Extra (2015) 0.79
Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy. Lab Invest (2010) 0.78
Cellular cholesterol transport proteins in diabetic nephropathy. PLoS One (2014) 0.78
Treatment and impact of dyslipidemia in diabetic nephropathy. Clin Exp Nephrol (2013) 0.78
Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol (2014) 0.78
The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice. Int J Mol Sci (2014) 0.78
Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury. Int J Biol Sci (2016) 0.78
Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells. Lipids Health Dis (2013) 0.77
The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr (2012) 0.77
Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis. J Anesth (2009) 0.77
Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol (2015) 0.77
Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio. Heart Vessels (2013) 0.76
Sesamin Ameliorates High-Fat Diet-Induced Dyslipidemia and Kidney Injury by Reducing Oxidative Stress. Nutrients (2016) 0.76
Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis. Inflammation (2015) 0.76
Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatr Nephrol (2015) 0.76
The lipid story in chronic kidney disease: a long story with a happy end? Int Urol Nephrol (2013) 0.76
Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice. J Biol Chem (2016) 0.75
Nephrology, dialysis and transplantation. Postgrad Med J (1990) 0.75
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia. Lipids Health Dis (2015) 0.75
The blood compatibilities of blood purification membranes and other materials developed in Japan. Int J Biomater (2011) 0.75
Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease. Indian J Clin Biochem (2008) 0.75
Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model. Int J Clin Exp Med (2015) 0.75
Role of apolipoprotein E in renal damage protection. Histochem Cell Biol (2011) 0.75
Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis (2017) 0.75
The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury. PLoS One (2015) 0.75
Association of renal function with clinical parameters and conditions in a longitudinal population-based epidemiological study. Biomed Rep (2016) 0.75
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes. PLoS One (2015) 0.75
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor. Sci Rep (2016) 0.75
Vitamin A deficiency results in dysregulation of lipid efflux pathway in rat kidney. Pediatr Nephrol (2010) 0.75
Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy. Int J Clin Exp Pathol (2015) 0.75
Protective effects of berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity. Int J Clin Exp Pathol (2015) 0.75
Management of progressive renal failure: the role of dietary manipulations. Postgrad Med J (1987) 0.75
Soy-based renoprotection. World J Nephrol (2016) 0.75
The kidney and lipids: preface. Clin Exp Nephrol (2014) 0.75
Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. Exp Ther Med (2017) 0.75
CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol (2017) 0.75
Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria. Pediatr Nephrol (2017) 0.75
Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med (1966) 2.91
Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest (1988) 2.77
Structure of a biological oxygen sensor: a new mechanism for heme-driven signal transduction. Proc Natl Acad Sci U S A (1998) 2.62
A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26
Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J Biol Chem (2001) 2.19
Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol (1967) 1.96
Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc (1987) 1.90
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol (2014) 1.85
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int (2001) 1.71
Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis. Hong Kong Med J (2008) 1.63
Insight into the catalytic mechanism of DNA polymerase beta: structures of intermediate complexes. Biochemistry (2001) 1.62
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation (2002) 1.58
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
The polyneuropathy of chronic renal failure. Brain (1971) 1.49
Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet (1976) 1.47
Scrape biopsy of malignant biliary stricture through percutaneous transhepatic biliary drainage tracts. AJR Am J Roentgenol (1989) 1.47
Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis (1989) 1.43
Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. Hong Kong Med J (2005) 1.43
Influence of fasting and sample collection time on 38 biochemical markers in healthy children: a CALIPER substudy. Clin Biochem (2012) 1.42
Continuous ambulatory peritoneal dialysis (CAPD): experience with the first 100 patients in a Hong Kong centre. Int J Artif Organs (1987) 1.41
The class-specific immunoglobulin composition of fluids obtained from various levels of the canine respiratory tract. J Immunol (1976) 1.40
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet (1972) 1.36
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
New mechanistic insights from structural studies of the oxygen-sensing domain of Bradyrhizobium japonicum FixL. Biochemistry (2000) 1.33
Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J Biol Chem (2001) 1.30
Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28
Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn (2012) 1.25
Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25
Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23
Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) (1983) 1.22
Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut (1978) 1.19
Conservatively managed patients with stage 5 chronic kidney disease--outcomes from a single center experience. QJM (2009) 1.18
Persistent sciatic artery complicated by aneurysm formation and thrombosis. Hong Kong Med J (2008) 1.17
Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16
Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int (1981) 1.15
Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.13
Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature (1969) 1.11
Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med (1966) 1.11
Home dialysis in children and adolescents. Proc Eur Dial Transplant Assoc (1972) 1.09
Structural basis for the design of antibiotics targeting peptide deformylase. Biochemistry (1999) 1.08
Acute renal failure after eating raw fish gall bladder. Br Med J (Clin Res Ed) (1985) 1.05
Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc (1973) 1.04
Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet (1976) 1.03
Efficiency of scintillation counting of tritium labelled DNA-protein in the mixed leucocyte reaction in vitro. Nature (1966) 1.02
The influence of permethrin-impregnated bednets and mass drug administration on the incidence of Plasmodium falciparum malaria in children in Sabah, Malaysia. Med Vet Entomol (1987) 1.01
Molecular characterization of the genes encoding the tungsten-containing aldehyde ferredoxin oxidoreductase from Pyrococcus furiosus and formaldehyde ferredoxin oxidoreductase from Thermococcus litoralis. J Bacteriol (1995) 1.00
Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia. Br Med J (1978) 0.99
Disorders of blood-lipids in renal disease. Lancet (1975) 0.99
Renal physiology revisited: amiloride. Lancet (1986) 0.98
Rejection encephalopathy. Proc Eur Dial Transplant Assoc (1981) 0.98
Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed) (1981) 0.97
Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) (1988) 0.97
Significance of high plasma renin activity in patients on maintenance haemodialysis therapy. Br Med J (1973) 0.96
Insulin resistance and iron overload. Ann Clin Biochem (1983) 0.96
Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother (1983) 0.96
Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant (1988) 0.96
Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy. Br Med J (1972) 0.95
Glomerular structures and lipids in progressive renal disease. Am J Med (1989) 0.95
A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals. Clin Biochem (2013) 0.95
Gut hormones and glomerular hyperfiltration. Lancet (1984) 0.94
Electrical measurement of the direct spin hall effect in Fe/InxGa(1-x)As heterostructures. Phys Rev Lett (2010) 0.94
Acute tubular necrosis due to rhabdomyolysis and pancreatitis associated with Salmonella enteritidis food poisoning. Nephrol Dial Transplant (1993) 0.94
Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet (1974) 0.93
Detection of cytomegalovirus by ELISA in urine samples is inhibited by beta 2 microglobulin. J Med Virol (1986) 0.93
Correction of hypocalcaemic symptoms during plasma exchange. Lancet (1976) 0.92
Plasma immunoreactive melanotrophic hormones in patients on maintenance haemodialysis. Br Med J (1975) 0.92
Gastrointestinal complications of dialysis related amyloidosis. BMJ (1988) 0.91
Nodular fasciitis: MRI appearance and literature review. Skeletal Radiol (2001) 0.91
Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant (1998) 0.90
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int (1993) 0.90
A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma. J Hepatol (2000) 0.90
Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant (2001) 0.90
Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation. J Neurol Sci (1982) 0.89
Neurologic injury after endovascular stent-graft and bilateral internal iliac artery embolization for infrarenal abdominal aortic aneurysm. J Vasc Interv Radiol (2001) 0.89
Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis. Lancet (1973) 0.89
Minimal change glomerulopathy in two patients after thymectomy. Singapore Med J (1990) 0.89
Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol (1991) 0.89